Nutrien (NTR) Misses Q1 EPS by 40c

Nutrien (NYSE: NTR) reported Q1 EPS of $1.11, $0.40 worse than the analyst estimate of $1.51. Revenue for the quarter came in at $6.11 billion versus the consensus estimate of $6.39 billion.

For earnings history and earnings-related data on Nutrien (NTR) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
• Vivos Therapeutics (VVOS) Tops Q2 EPS by 6c